Jim Cramer Notes Kimberly-Clark’s Stock Got “Clobbered” After Kenvue Acquisition Announcement

Group 1 - Kimberly-Clark Corporation is acquiring Kenvue, the maker of well-known brands such as Tylenol, Band-Aids, and Neutrogena, which has impacted its stock performance negatively [1] - The company has transitioned from a domestic entity to a global powerhouse, experiencing significant growth in its market presence [1] - Kimberly-Clark's product offerings include personal care and household items like diapers, wipes, feminine and adult care products, tissues, paper towels, and soaps [2] Group 2 - There is a belief that certain AI stocks may present greater upside potential and lower downside risk compared to Kimberly-Clark as an investment option [3]